Insight Molecular Diagnostics Net Income
| IMDX Stock | 6.69 0.17 2.48% |
As of the 4th of February, Insight Molecular retains the Risk Adjusted Performance of 0.0541, downside deviation of 4.65, and Market Risk Adjusted Performance of 0.1244. Insight Molecular technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Insight Molecular Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 14.1147 | Revenue | Earnings Share (3.79) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -54.6 M | -51.9 M | |
| Net Loss | -54.6 M | -57.3 M | |
| Net Loss | (4.18) | (4.39) | |
| Net Income Per E B T | 1.01 | 1.31 |
Insight | Net Income | Build AI portfolio with Insight Stock |
The evolution of Net Income for Insight Molecular Diagnostics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Insight Molecular compares to historical norms and industry peers.
Latest Insight Molecular's Net Income Growth Pattern
Below is the plot of the Net Income of Insight Molecular Diagnostics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Insight Molecular financial statement analysis. It represents the amount of money remaining after all of Insight Molecular Diagnostics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Insight Molecular's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (60.66 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Insight Net Income Regression Statistics
| Arithmetic Mean | (26,950,916) | |
| Coefficient Of Variation | (90.37) | |
| Mean Deviation | 20,374,371 | |
| Median | (19,375,000) | |
| Standard Deviation | 24,355,098 | |
| Sample Variance | 593.2T | |
| Range | 69.4M | |
| R-Value | (0.86) | |
| Mean Square Error | 167.5T | |
| R-Squared | 0.74 | |
| Significance | 0.000011 | |
| Slope | (4,135,678) | |
| Total Sum of Squares | 9490.7T |
Insight Net Income History
Other Fundumenentals of Insight Molecular
Insight Molecular Net Income component correlations
Insight Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Insight Molecular is extremely important. It helps to project a fair market value of Insight Stock properly, considering its historical fundamentals such as Net Income. Since Insight Molecular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insight Molecular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insight Molecular's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insight Molecular. Market participants price Insight higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Insight Molecular assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.79) | Revenue Per Share | Quarterly Revenue Growth 11.148 | Return On Assets | Return On Equity |
Understanding Insight Molecular requires distinguishing between market price and book value, where the latter reflects Insight's accounting equity. The concept of intrinsic value - what Insight Molecular's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Insight Molecular's price substantially above or below its fundamental value.
Please note, there is a significant difference between Insight Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insight Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Insight Molecular's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Insight Molecular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Insight Molecular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Insight Molecular.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Insight Molecular on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Insight Molecular Diagnostics or generate 0.0% return on investment in Insight Molecular over 90 days. Insight Molecular is related to or competes with C4 Therapeutics, Sangamo Therapeutics, Cybin, OmniAb, Prelude Therapeutics, Codexis, and Armata Pharmaceuticals. Insight Molecular is entity of United States More
Insight Molecular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Insight Molecular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Insight Molecular Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.65 | |||
| Information Ratio | 0.0514 | |||
| Maximum Drawdown | 22.08 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 9.03 |
Insight Molecular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insight Molecular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Insight Molecular's standard deviation. In reality, there are many statistical measures that can use Insight Molecular historical prices to predict the future Insight Molecular's volatility.| Risk Adjusted Performance | 0.0541 | |||
| Jensen Alpha | 0.1847 | |||
| Total Risk Alpha | 0.0074 | |||
| Sortino Ratio | 0.0544 | |||
| Treynor Ratio | 0.1144 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Insight Molecular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Insight Molecular February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0541 | |||
| Market Risk Adjusted Performance | 0.1244 | |||
| Mean Deviation | 3.91 | |||
| Semi Deviation | 4.33 | |||
| Downside Deviation | 4.65 | |||
| Coefficient Of Variation | 1609.9 | |||
| Standard Deviation | 4.93 | |||
| Variance | 24.28 | |||
| Information Ratio | 0.0514 | |||
| Jensen Alpha | 0.1847 | |||
| Total Risk Alpha | 0.0074 | |||
| Sortino Ratio | 0.0544 | |||
| Treynor Ratio | 0.1144 | |||
| Maximum Drawdown | 22.08 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 9.03 | |||
| Downside Variance | 21.66 | |||
| Semi Variance | 18.73 | |||
| Expected Short fall | (4.09) | |||
| Skewness | 0.3746 | |||
| Kurtosis | (0.34) |
Insight Molecular Backtested Returns
At this stage we consider Insight Stock to be relatively risky. Insight Molecular holds Efficiency (Sharpe) Ratio of 0.0337, which attests that the entity had a 0.0337 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Insight Molecular, which you can use to evaluate the volatility of the firm. Please check out Insight Molecular's Downside Deviation of 4.65, market risk adjusted performance of 0.1244, and Risk Adjusted Performance of 0.0541 to validate if the risk estimate we provide is consistent with the expected return of 0.17%. Insight Molecular has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 2.59, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Insight Molecular will likely underperform. Insight Molecular right now retains a risk of 4.99%. Please check out Insight Molecular value at risk, as well as the relationship between the skewness and price action indicator , to decide if Insight Molecular will be following its current trending patterns.
Auto-correlation | 0.06 |
Virtually no predictability
Insight Molecular Diagnostics has virtually no predictability. Overlapping area represents the amount of predictability between Insight Molecular time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Insight Molecular price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Insight Molecular price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Insight Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Insight Molecular Diagnostics reported net income of (60.66 Million). This is 117.78% lower than that of the Health Care Equipment & Supplies sector and 135.04% lower than that of the Health Care industry. The net income for all United States stocks is 110.62% higher than that of the company.
Insight Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insight Molecular's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insight Molecular could also be used in its relative valuation, which is a method of valuing Insight Molecular by comparing valuation metrics of similar companies.Insight Molecular is currently under evaluation in net income category among its peers.
Insight Molecular ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Insight Molecular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Insight Molecular's managers, analysts, and investors.Environmental | Governance | Social |
Insight Fundamentals
| Return On Equity | -4.29 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (2.73) % | ||||
| Current Valuation | 54.24 M | ||||
| Shares Outstanding | 28.6 M | ||||
| Shares Owned By Insiders | 22.03 % | ||||
| Shares Owned By Institutions | 56.30 % | ||||
| Number Of Shares Shorted | 203.82 K | ||||
| Price To Book | 8.00 X | ||||
| Price To Sales | 22.55 X | ||||
| Revenue | 1.88 M | ||||
| Gross Profit | 2.09 M | ||||
| EBITDA | (59.02 M) | ||||
| Net Income | (60.66 M) | ||||
| Total Debt | 3.66 M | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (20.71 M) | ||||
| Short Ratio | 6.44 X | ||||
| Earnings Per Share | (3.79) X | ||||
| Target Price | 5.42 | ||||
| Number Of Employees | 46 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 86.66 M | ||||
| Total Asset | 35.08 M | ||||
| Retained Earnings | (350.54 M) | ||||
| Working Capital | 4.48 M | ||||
| Net Asset | 35.08 M |
About Insight Molecular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insight Molecular Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insight Molecular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insight Molecular Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.